Inventor · disambiguated record
Veronique Zennou
Also filed as: ZENNOU VERONIQUE
18 granted patents·5 pending applications·361 citations·filing 1998–2022
95Inventor score
Top patents by PatentIndex Score
23 records- 0197US6682907B1Use of triplex structure DNA in transferring nucleotide sequencesPASTEUR INSTITUT·Filed 2000·Granted Jan 27, 2004·198 cites·41 claims
- 0292US8093042B2Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNACHARNEAU PIERRE·Filed 2005·Granted Jan 10, 2012·26 cites·62 claims
- 0391US10407695B2Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNAPASTEUR INSTITUT·Filed 2015·Granted Sep 10, 2019·13 cites·10 claims
- 0491US8349606B2Lentiviral vectors for the preparation of immunotherapeutical compositionsPASTEUR INSTITUT·Filed 2011·Granted Jan 8, 2013·10 cites·20 claims
- 0591US7981671B2Use of triplex structure DNA in transferring nucleotide sequencesPASTEUR INSTITUT·Filed 2008·Granted Jul 19, 2011·12 cites·24 claims
- 0689US8367068B2Use of triplex structure DNA in transferring nucleotide sequencesPASTEUR INSTITUT·Filed 2010·Granted Feb 5, 2013·5 cites·26 claims
- 0788US8460678B2Use of triplex structure DNA in transferring nucleotide sequencesCHARNEAU PIERRE·Filed 2011·Granted Jun 11, 2013·5 cites·14 claims
- 0887US7968332B2Lentiviral vectors for the preparation of immunotherapeutical compositionsPASTEUR INSTITUT·Filed 2002·Granted Jun 28, 2011·16 cites·23 claims
- 0986US8450087B2Use of triplex structure DNA in transferring nucleotide sequencesCHARNEAU PIERRE·Filed 2011·Granted May 28, 2013·4 cites·20 claims
- 1082US8652807B2Lentiviral vectors for the preparation of immunotherapeutical compositionsPASTEUR INSTITUT·Filed 2012·Granted Feb 18, 2014·4 cites·25 claims
- 1181US8512993B2Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNACHARNEAU PIERRE·Filed 2011·Granted Aug 20, 2013·4 cites·20 claims
- 1279US8512994B2Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNACHARNEAU PIERRE·Filed 2011·Granted Aug 20, 2013·3 cites·18 claims
- 1376US9238824B2Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNAPASTEUR INSTITUT·Filed 2013·Granted Jan 19, 2016·2 cites·20 claims
- 1476US6103462ARapid single-cycle assay for human immunodeficiency virus type-1 drug resistancePASTEUR INSTITUT·Filed 1998·Granted Aug 15, 2000·56 cites·18 claims
- 1573US12359199B2Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymesMEIRAGTX UK II LTD·Filed 2022·Granted Jul 15, 2025·0 cites·25 claims
- 1667US6558923B2Rapid single-cycle assay for human immunodeficiency virus type 1 drug resistancePASTEUR INSTITUT·Filed 2001·Granted May 6, 2003·3 cites·18 claims
- 1763US2006040347A1Use of triplex structure DNA in transferring nucleotide sequencesCHARNEAU PIERRE·Filed 2003·Application pending·0 cites
- 1863US2019119699A1Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dnaPASTEUR INSTITUT·Filed 2018·Application pending·0 cites
- 1963US2018346928A1Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dnaPASTEUR INSTITUT·Filed 2018·Application pending·0 cites
- 2055US11512310B2Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymesMEIRAGTX UK II LTD·Filed 2017·Granted Nov 29, 2022·0 cites·23 claims
- 2148US10894093B2Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivationCELLECTIS·Filed 2017·Granted Jan 19, 2021·0 cites·21 claims
- 2245US2003194392A1Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNAFiled 2002·Application pending·0 cites
- 2344US2019032088A1Micelle based system nuclease encapsulation for in-vivo gene editingCELLECTIS·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Veronique Zennou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →